References
- Emilsson L, Lindahl B, Koster M, Lambe M, Ludvigsson JF. Review of 103 Swedish healthcare quality registries. J Intern Med. 2015;277:94–136.
- Wallerstedt SM, Wettermark B, Hoffmann M. The first decade with the Swedish Prescribed Drug Register – a systematic review of the output in the scientific literature. Basic Clin Pharmacol Toxicol. 2016;119:464–9.
- Chung SC, Gedeborg R, Nicholas O, James S, Jeppsson A, Wolfe C, et al. Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK. Lancet. 2014;383:1305–12.
- Hellgren K, Dreyer L, Arkema EV, Glintborg B, Jacobsson LT, Kristensen LE, et al. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers. Ann Rheum Dis. 2017;76:105–11.
- Helgesson C-F, Johansson Krafve L. The compound collaborations of clinical registries. In: Penders B, Vermeulen N, Parker JN, editors. The CompHealthy Collaboration: collaboration across health research and medical care. Farnham: Ashgate; 2015.
- Verstappen SM, Askling J, Berglind N, Franzen S, Frisell T, Garwood C, et al. Methodological challenges when comparing demographic and clinical characteristics of international observational registries. Arthritis Care Res. 2015;67:1637–45.
- Hoffmann VS, Baccarani M, Hasford J, Lindoerfer D, Burgstaller S, Sertic D, et al. The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries. Leukemia. 2015;29:1336–43.
- Swedish National Quality Registries. Available at: http://www.kvalitetsregister.se/englishpages.2040.html (accessed 27 April 2016).
- Monitoring of drug effects in clinical practice - an EU perspective (EU-uppföljning om läkemedelseffekter i klinisk vardag). Medical Product Agency 2011. Available at: https://lakemedelsverket.se/upload/nyheter/2012/Rapport%20EU-uppf%c3%b6ljning%20i%20klinisk%20vardag%202011-12-23.pdf (accessed 27 April 2016).
- Glynn D, Campbell B, Marlow M, Patrick H. How to improve the quality of evidence when new treatments are funded conditional on collecting evidence of effectiveness and safety. J Health Serv Res Policy. 2016;21:71–2.
- National Institute for Health and Care Excellence. Introduction. In: Interventional procedures programme manual. Available at: https://www.nice.org.uk/article/pmg28/chapter/1%20Introduction (accessed 9 May 2016).
- Datainspektionen [The Swedish Data Protection Authority]. The Personal Data Act 1998 (Personuppgiftslagen 1998:204). Available at: http://www.datainspektionen.se/in-english/legislation/the-personal-data-act/ (accessed 3 June 2016).
- Swedish Patient Data Act 2008 (Patientdatalag) (SOU 2008:355). Available at: http://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/patientdatalag-2008355_sfs-2008-355 (accessed 3 June 2016).
- Eriksson JK, Neovius M, Ernestam S, Lindblad S, Simard JF, Askling J. Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res. 2013;65:870–8.
- Frobert O, Lagerqvist B, Olivecrona GK, Omerovic E, Gudnason T, Maeng M, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369:1587–97.
- Lauer MS, D'Agostino RB Sr. The randomized registry trial–the next disruptive technology in clinical research? N Engl J Med. 2013;369:1579–81.
- Olsson T, Achiron A, Alfredsson L, Berger T, Brassat D, Chan A, et al. Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort. Mult Scler. 2013;19:1533–8.
- Strangfeld A, Hyrich K, Askling J, Arkema E, Davies R, Listing J, et al. Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers. Rheumatology (Oxford). 2011;50:146–51.
- McKnight JA, Wild SH, Lamb MJ, Cooper MN, Jones TW, Davis EA, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2015;32:1036–50.
- Michaud K, Berglind N, Franzen S, Frisell T, Garwood C, Greenberg JD, et al. Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease. Ann Rheum Dis. 2016;75:1797–805.
- Hillert J, Stawiarz L. The Swedish MS registry - clinical support tool and scientific resource. Acta Neurol Scand. 2015;132:11–19.
- European Union. Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. Available at: http://ec.europa.eu/health/files/eudralex/vol-1/reg_2014_536/reg_2014_536_en.pdf (accessed 21 October 2016).